Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM)

Price 264.00p on 15-11-2024 at 17:30:00
Change -1.00p -0.38%
Buy 266.00p
Sell 264.00p
Buy / Sell HCM Shares
Last Trade: Sell 6,239.00 at 264.00p
Day's Volume: 39,973
Last Close: 264.00p
Open: 264.00p
ISIN: KYG4672N1198
Day's Range 261.00p - 269.00p
52wk Range: 190.40p - 353.00p
Market Capitalisation: £2,256m
VWAP: 264.48537p
Shares in Issue: 855m

Recent Trades History Hutchmed (HCM)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 6,239 264.00p Uncrossing Trade
16:35:22 - 15-Nov-24
Sell* 123 265.00p Automatic Execution
16:28:25 - 15-Nov-24
Sell* 128 265.00p Automatic Execution
16:28:25 - 15-Nov-24
Buy* 124 266.00p Automatic Execution
16:28:25 - 15-Nov-24
Buy* 120 265.00p Automatic Execution
16:26:42 - 15-Nov-24
Buy* 46 265.00p Automatic Execution
16:24:20 - 15-Nov-24
Buy* 10 265.00p Automatic Execution
16:24:20 - 15-Nov-24
Buy* 61 265.00p Automatic Execution
16:24:20 - 15-Nov-24
Buy* 114 265.00p Automatic Execution
16:18:24 - 15-Nov-24
Buy* 34 265.00p Automatic Execution
16:13:00 - 15-Nov-24

Share Price History for Hutchmed

Time period:
to
Date Open High Low Close Volume

Share News for Hutchmed

Hutchmed China receives first milestone payment for Takeda drug sales

31st Oct 2024 12:02

(Alliance News) - Hutchmed (China) Ltd on Thursday said it will receive a USD20 million payment from its partner Takeda Pharmaceutical Co Ltd which achieved a net sales milestone. Read More

TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results

16th Oct 2024 09:52

(Alliance News) - Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in patients with a form of lung cancer. Read More

AIM WINNERS & LOSERS: Windward rises; Hutchmed recovers

10th Oct 2024 10:20

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

24th Sep 2024 08:49

(Alliance News) - Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. Read More

Hutchmed "disappointed" as it withdraws fruquintinib application

30th Aug 2024 12:24

(Alliance News) - Hutchmed (China) Ltd announced on Friday that it has voluntarily withdrawn its supplemental new drug application for fruquintinib in China. Read More

FTSE 100 Latest
Value8,063.61
Change-7.58

Login to your account

Forgot Password?

Not Registered